Researchers have been excited about the medication , a novel dual agonist showing promising outcomes in clinical trials for body reduction . It functions by targeting several pathways : GLP-1 and GIP, https://victorfulk842281.blogscribble.com/41024389/the-new-prospect-for-weight-loss